updated chart, page-395

bj82.., results first, then (if applicable) phase upgrade.
True, SYC suggested keeping the ptx100 in-house and going it alone (some time back).
Yet things can change, for example that was prior to the acquisition of the Omnicart.
As philley stated ( and many others too), there was ( and possibility is more so now) a high interest on the results of this trial by big Pharma. If so, then the possibility of a CR may result if kept in-house some time away or funds for a prospective phase 3 or a conventional phase 2 continuation may be offered by an outside source.
In the meantime, enjoy the ride.